Browsing by Author Nikas, S. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 15 of 15
TitleAuthor(s)Issue date
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitisKiortsis, D. N.; Mavridis, A. K.; Vasakos, S.; Nikas, S. N.; Drosos, A. A.24-Nov-2015
Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitisKiortsis, D. N.; Mavridis, A. K.; Filippatos, T. D.; Vasakos, S.; Nikas, S. N.; Drosos, A. A.24-Nov-2015
Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled studyNikas, S. N.; Voulgari, P. V.; Alamanos, Y.; Papadopoulos, C. G.; Venetsanopoulou, A. I.; Georgiadis, A. N.; Drosos, A. A.24-Nov-2015
Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatmentNikas, S. N.; Voulgari, P. V.; Takalou, I. P.; Katsimbri, P.; Drosos, A. A.24-Nov-2015
Infliximab therapy in established rheumatoid arthritis: an observational studyVoulgari, P. V.; Alamanos, Y.; Nikas, S. N.; Bougias, D. V.; Temekonidis, T. I.; Drosos, A. A.24-Nov-2015
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month studyTemekonidis, T. I.; Alamanos, Y.; Nikas, S. N.; Bougias, D. V.; Georgiadis, A. N.; Voulgari, P. V.; Drosos, A. A.24-Nov-2015
Infliximab treatment in ankylosing spondylitis: an observational studyNikas, S. N.; Alamanos, Y.; Voulgari, P. V.; Pliakou, X. I.; Papadopoulos, C. G.; Drosos, A. A.24-Nov-2015
Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritisPanoulas, V. F.; Nikas, S. N.; Smith, J. P.; Douglas, K. M.; Nightingale, P.; Milionis, H. J.; Treharne, G. J.; Toms, T. E.; Kita, M. D.; Kitas, G. D.24-Nov-2015
Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumabZikou, A. K.; Argyropoulou, M. I.; Voulgari, P. V.; Xydis, V. G.; Nikas, S. N.; Efremidis, S. C.; Drosos, A. A.24-Nov-2015
Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with infliximabArgyropoulou, M. I.; Glatzouni, A.; Voulgari, P. V.; Xydis, V. G.; Nikas, S. N.; Efremidis, S. C.; Drosos, A. A.24-Nov-2015
Meloxicam-induced erythema multiformeNikas, S. N.; Kittas, G.; Karamaounas, N.; Drosos, A. A.24-Nov-2015
Onercept. SeronoNikas, S. N.; Drosos, A. A.24-Nov-2015
SCIO-469 Scios IncNikas, S. N.; Drosos, A. A.24-Nov-2015
Treatment of resistant rheumatoid arthritis by intra-articular infliximab injections: a pilot studyNikas, S. N.; Temekonidis, T. I.; Zikou, A. K.; Argyropoulou, M. I.; Efremidis, S.; Drosos, A. A.24-Nov-2015
Urticaria and angiedema-like skin reactions in a patient treated with adalimumabNikas, S. N.; Voulgari, P. V.; Drosos, A. A.24-Nov-2015